1-3 of 3
Werner Rabitsch, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clofarabine/Cyclophosphamide (ClofCy) for Debulking refractory Acute Leukemias Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Werner Rabitsch, M.D., Alexandra Boehm, MD, Peter Schellongowski, MD, Peter Kalhs, MD, Peter Valent, MD, Wolfgang R Sperr, MD
Journal: Blood
Blood (2012) 120 (21): 4504.
https://doi.org/10.1182/blood.V120.21.4504.4504
Published: 2012
Journal Articles

BCR/ABL+ CML Stem Cells (CD34+/CD38-) Express High Levels of CD33 and Are Responsive to a CD33-Targeting Drug: a New Potential Concept for Eradication of CML Stem Cells.

Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M., Karoline V. Gleixner, M.D., Katharina Blatt, M.Sc., Susanne Herndlhofer, Hermine Agis, M.D., Werner Rabitsch, M.D., Berthold Streubel, M.D., Gerlinde Mitterbauer-Hohendanner, M.D., Wolfgang R. Sperr, M.D., Christian Sillaber, M.D., Peter Valent, M.D.
Journal: Blood
Blood (2010) 116 (21): 3382.
https://doi.org/10.1182/blood.V116.21.3382.3382
Published: 2010
Journal Articles

Identification of Novel Surface Markers and Targets In Neoplastic Stem Cells In AML and CML: a Flow-Gene-Flow Screen Approach.

Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M., Irina Sadovnik, M.Sc., Viviane Winter, M.D., Katharina Blatt, M.Sc., Werner Rabitsch, M.D., Wolfgang R. Sperr, M.D., Elena De Angelis, Ph.D., Steve Holmes, Ph.D., Peter Valent, M.D.
Journal: Blood
Blood (2010) 116 (21): 1575.
https://doi.org/10.1182/blood.V116.21.1575.1575
Published: 2010